title: Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins.
abstract: OBJECTIVE
  To investigate the enzymatic activity of hepatic lipase (HL) in postmenopausal women (PMW) and reproductive age women (RAW); and to evaluate the relationship between this enzyme and the atherogenic intermediate density lipoproteins (IDL) and low density lipoproteins (LDL), and antiatherogenic high density lipoproteins (HDL) and its subfractions (HDL2 and HDL3).
  
  
  METHODS
  We studied 55 PMW receiving no hormonal treatment in a cross-sectional study in comparison with a control group of 55 RAW, matched by body mass index. Follicle-stimulating hormone was > 40 mUI/ml in PMW and 3-12 mUI/ml in RAW. PMW presented at least 1 year of natural menopause and no more than 10 years of amenorrhea with E2 serum concentration < 15 pg/ml.
  
  
  RESULTS
  HL activity was significantly higher in PMW versus RAW (14.0 +/- 1.4 vs. 10.9 +/- 0.4 micromol of fatty acids/ml of postheparin plasma, respectively, mean +/- SEM, p < 0.001). In PMW, IDL cholesterol showed a positive correlation with LDL cholesterol (r = 0.28, p < 0.05), and HDL2 cholesterol was inversely correlated with HL activity (r = 0.31, p < 0.05). HL was positively correlated with plasma concentration of LDL cholesterol in both groups (r = 0.27, p < 0.05). The higher values of HL activity and IDL cholesterol were independent of age.
  
  
  CONCLUSIONS
  Higher HL activity is associated with a more atherogenic profile in PMW.
authors.affiliation: Department of Clinical Biochemistry of the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina.
authors.forename: G A
authors.initials: GA
authors.lastname: Berg
authors.forename: N
authors.initials: N
authors.lastname: Siseles
authors.forename: A I
authors.initials: AI
authors.lastname: González
authors.forename: O C
authors.initials: OC
authors.lastname: Ortiz
authors.forename: A
authors.initials: A
authors.lastname: Tempone
authors.forename: R W
authors.initials: RW
authors.lastname: Wikinski
mesh_terms: D001161:Arteriosclerosis / Q000097:blood*; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D003430:Cross-Sectional Studies; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008049:Lipase / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D053419:Lipoproteins, IDL; D008077:Lipoproteins, LDL / Q000097:blood*; D008099:Liver / Q000201:enzymology*; D017698:Postmenopause / Q000097:blood*
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D008074:Lipoproteins; D053419:Lipoproteins, IDL; D008077:Lipoproteins, LDL; C030104:lipoprotein cholesterol; D004958:Estradiol; D005640:Follicle Stimulating Hormone; D002784:Cholesterol; D008049:Lipase